https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-222007-01-01 00:00:002019-02-15 09:17:01Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-62007-01-01 00:00:002019-02-15 09:19:41Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Drugs Aging 2007;24(3):197-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Drugs Aging 2007;24(3):197-2212007-01-01 00:00:002019-02-15 09:24:11Advances in prostate cancer immunotherapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-862006-12-23 00:00:002019-02-15 08:50:18Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-72006-12-19 00:00:002019-02-15 09:19:44Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-302006-12-15 00:00:002019-02-15 08:44:39Steady-state and inflammatory dendritic-cell development
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-712
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-7122006-12-01 00:00:002019-02-15 08:35:06Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Ann. Surg. 2006 Dec;244(6):986-92; discussion 992-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Ann. Surg. 2006 Dec;244(6):986-92; discussion 992-32006-12-01 00:00:002020-06-23 09:36:05Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Oncol. Rep. 2006 Dec;16(6):1317-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Oncol. Rep. 2006 Dec;16(6):1317-242006-12-01 00:00:002019-02-15 08:38:15Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-702006-12-01 00:00:002019-02-15 08:59:55[Dendritic cells and gliomas: a hope in immunotherapy?]
